Clinical outcome of children with BCR/ABL and ALL1/AF4 positive acute lymphoblastic leukemia

被引:0
|
作者
Sarper, N [1 ]
Özbek, U [1 ]
Agaoglu, L [1 ]
Anak, S [1 ]
Devecioglu, Ö [1 ]
Özgen, Ü [1 ]
Kandilci, A [1 ]
Yalman, N [1 ]
Biner, B [1 ]
Gedikoglu, G [1 ]
机构
[1] Istanbul Univ, Istanbul Sch Med, Our Children Leukemia Fdn, Ctr Hlth, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:110 / 111
页数:2
相关论文
共 50 条
  • [31] Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
    Maletzke, Saskia
    Salimi, Azam
    Vieri, Margherita
    Schroeder, Kema Marlen
    Schemionek, Mirle
    Masouleh, Behzad Kharabi
    Brummendorf, Tim H.
    Koschmieder, Steffen
    Appelmann, Iris
    PLOS ONE, 2022, 17 (10):
  • [32] The clinical outcome of adult Philadelphia (Ph)-positive acute lymphoblastic leukemia (ALL).
    Faderl, S
    Kantajian, HM
    Thomas, D
    Cortes, J
    Giles, F
    Estrov, Z
    BLOOD, 1998, 92 (10) : 225A - 225A
  • [33] BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
    Fu, Shuang
    Li, Mengqi
    Wang, Hongtao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] RB1 is frequently altered in adult, BCR/ABL plus acute lymphoblastic leukemia (ALL).
    Gutierrez-Hernandez, O
    Salles, MT
    Vidal-Millan, S
    Sobrevilla-Calvo, P
    Cervera, E
    Rivas-Vera, S
    Zeichner, I
    BLOOD, 2003, 102 (11) : 221B - 221B
  • [35] MOLECULAR ANALYSIS OF MLL-1/AF4 RECOMBINATION IN INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA
    BORKHARDT, A
    REPP, R
    HAUPT, E
    BRETTREICH, S
    BUCHEN, U
    GOSSEN, R
    LAMPERT, F
    LEUKEMIA, 1994, 8 (04) : 549 - 553
  • [36] Ikzf1 haploinsufficiency contributes to the pathogenesis of BCR-ABL1 positive acute lymphoblastic leukemia
    Collins-Underwood, J. Racquel
    Miller, Christopher
    Downing, James
    Mullighan, Charles
    CANCER RESEARCH, 2009, 69
  • [37] Identification Of FOXM1 As Therapeutic Target In BCR-ABL1 Positive Acute Lymphoblastic Leukemia
    Buchner, Maike
    Park, Eugene
    Klemm, Lars
    Geng, Huimin
    Kopanja, Dragana
    Raychaudhuri, Pradip
    Muschen, Markus
    BLOOD, 2013, 122 (21)
  • [38] Clinical implications of cytogenetic heterogeneities in BCR-ABL1 fusion positive adult B cell acute lymphoblastic leukemia
    Lu, Xinyan
    CANCER GENETICS, 2018, 224 : 53 - 53
  • [39] Clinical Implications of Cytogenetic Heterogeneity in BCR-ABL1 Fusion Positive Adult B Cell Acute Lymphoblastic Leukemia
    Lu, X.
    Medeiros, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S6 - S6
  • [40] The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL)
    Iacobucci, I.
    Ferrari, A.
    Lonetti, A.
    Papayannidis, C.
    Paoloni, F.
    Abbenante, M.
    Guadagnuolo, V.
    Ottaviani, E.
    Cattina, F.
    Vitale, A.
    Paolini, S.
    Soverini, S.
    Parisi, S.
    Vignetti, M.
    Baccarani, M.
    Martinelli, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)